Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.


Status message

Start your free, no obligation 5-day trial to continue exploring with full access.

Gottlieb approved as FDA commissioner

Joe Mont | May 10, 2017

The Senate has confirmed President Donald J. Trump’s pick to head the Food and Drug Administration, Dr. Scott Gottlieb, by a 57-42 vote.

Gottlieb, confirmed on May 9, will oversee a staff of 15,000 at the agency, which is responsible for evaluating and approving pharmaceuticals and medical devises.

The new commissioner has held previous positions at the FDA. In 2005, Gottlieb was appointed the FDA’s Deputy Commissioner for Medical and Scientific Affairs. He also has served as a senior advisor to the FDA Commissioner, and as the agency’s Director of Medical Policy Development.

Gottlieb earned a B.A. in economics, from Wesleyan University and an M.D. from the Mount Sinai School of Medicine. His residency in internal medicine was at Mount Sinai Medical Center

In a statement, Senate health committee Chairman Lamar Alexander (R-Tenn.) suggested that Gottlieb’s leadership at the FDA “will help American families.”

“The FDA has always been important—but...

Read this single article for $49, or click the subscribe button below to review subscription options.

Enjoy unlimited access to thousands of articles, browse five years of digital magazines, qualify for reduced admission to events, and more.